Sanjeev Nanda, a British-Indian entrepreneur based in Dubai has invested in ISHVAN Pharmaceuticals Ltd to develop the pharmaceutical infrastructure of Russia. The company will focus on bringing in inexpensive and innovative medical drugs and devices to new pharmaceutical markets. Cipla, Laurus, and Myla are some of the Indian companies that have entered into negotiations with ISHVAN for this initiative.
Subscribe to:
Post Comments (Atom)
-
China has been unkind to the U.S. Internet giants Google, Facebook and Amazon.com. But as a growing China spurs demand for foreign...
-
Sachin Dev Duggal and his college mate Saurav Dhoot. Duggal, a serial entrepreneur, holds an engineering degree from Imperial College, L...
-
Darren Huston knows all about hotel rooms — staying in one at least 80 days a year for his job. As chief executive officer of Bookin...
No comments:
Post a Comment